$CNO
CNO Financial Group, Inc. Stock $cno

$cno Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000122460818000045 Filed on November 05, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$778.2M	$1.481B	$1.079B
YoY Change	-28.61%	37.24%	6.24%
Cost Of Revenue		$646.9M	$638.1M
YoY Change		1.38%	4.64%
Gross Profit		$834.3M	$441.2M
YoY Change		89.1%	8.64%
Gross Profit Margin		56.33%	40.88%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$701.4M	$1.982B	$913.8M
YoY Change	-24.52%	116.92%	-2.5%
Operating Profit		$109.0M	-$472.6M
YoY Change		-123.06%	-11.01%
Interest Expense	-$39.70M	$38.80M	$30.10M
YoY Change	26.43%	28.9%	2.38%
% of Operating Profit		35.6%
Other Income/Expense, Net		$0.00
YoY Change
Pretax Income	$37.10M	-$539.8M	$129.9M
YoY Change	-70.41%	-515.55%	163.49%
Income Tax	$8.800M	-$10.00M	$29.10M
% Of Pretax Income	23.72%		22.4%
Net Earnings	$28.30M	-$529.8M	$100.8M
YoY Change	-139.92%	-625.6%	441.94%
Net Earnings / Revenue	3.64%	-35.77%	9.34%
Basic Earnings Per Share	$0.17	-$3.22	$0.60
Diluted Earnings Per Share	$0.17	-$3.22	$0.59
COMMON SHARES
Basic Shares Outstanding	164.6M shares	164.6M shares	168.7M shares
Diluted Shares Outstanding		164.6M shares	171.0M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$656.6M	$595.6M	$871.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$23.00B	$23.36B	$27.06B
YoY Change	-17.44%	-13.68%	1.24%
Other Assets	$630.0M	$578.0M	$567.0M
YoY Change	71.66%	1.94%	-6.59%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$31.44B	$31.65B	$32.70B
YoY Change	-5.05%	-3.23%	0.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$3.980B	$3.980B	$3.760B
YoY Change	0.2%	5.85%	-11.53%
Other Long-Term Liabilities	$632.0M	$690.0M	$789.0M
YoY Change	-15.96%	-12.55%	8.08%
Total Long-Term Liabilities	$4.612B	$4.670B	$4.549B
YoY Change	-2.37%	2.66%	-8.65%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$4.612B	$4.670B	$4.549B
Total Liabilities	$28.07B	$28.03B	$27.82B
YoY Change	-0.69%	0.73%	-0.37%
SHAREHOLDERS EQUITY
Retained Earnings	$196.6M	$184.8M	$851.9M
YoY Change	-64.92%	-78.31%	97.98%
Common Stock	$2.997B	$3.032B	$3.096B
YoY Change	-2.55%	-2.09%	-3.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.371B	$3.620B	$4.882B
YoY Change
Total Liabilities & Shareholders Equity	$31.44B	$31.65B	$32.70B
YoY Change	-5.05%	-3.23%	0.88%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	$28.30M	-$529.8M	$100.8M
YoY Change	-139.92%	-625.6%	441.94%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$202.8M	-$128.7M	$163.5M
YoY Change	10.34%	-178.72%	-33.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$211.1M	-$73.70M	$97.70M
YoY Change	-60.49%	-175.44%	-310.11%
Cash From Investing Activities	-$211.1M	-$73.70M	$97.70M
YoY Change	-60.49%	-175.44%	-310.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	69.30M	52.30M	-329.3M
YoY Change	-70.64%	-115.88%	-569.09%
NET CHANGE
Cash From Operating Activities	202.8M	-128.7M	163.5M
Cash From Investing Activities	-211.1M	-73.70M	97.70M
Cash From Financing Activities	69.30M	52.30M	-329.3M
Net Change In Cash	61.00M	-150.1M	-68.10M
YoY Change	-153.28%	120.41%	-125.33%
FREE CASH FLOW
Cash From Operating Activities	$202.8M	-$128.7M	$163.5M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-295800000	USD
CY2018Q3	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-5000000	USD
CY2017Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-292600000	USD
CY2018Q3	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-56100000	USD
CY2017Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-94000000	USD
CY2018Q3	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-4500000	USD
CY2017Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-335400000	USD
CY2018Q3	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-109700000	USD
CY2017Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	2600000	USD
CY2018Q3	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	1600000	USD
CY2017Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	2227300000	USD
CY2018Q3	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	577200000	USD
CY2018Q3	cno	Aggregate Growth Rateforthe Next Five Years Includedin Deferred Tax Valuation Analysis AggregateGrowthRatefortheNextFiveYearsIncludedinDeferredTaxValuationAnalysis	0.03
CY2017Q3	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	700000	USD
	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	1000000	USD
CY2018Q3	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	-500000	USD
	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	-100000	USD
CY2018Q3	cno	Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent	0.55
CY2018Q3	cno	Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent	0.92
CY2017Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	15334100000	USD
CY2018Q3	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	13228400000	USD
CY2017Q4	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	17275500000	USD
CY2018Q3	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	13640400000	USD
	cno	Available For Sale Securities Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income Loss AvailableForSaleSecuritiesOtherThanTemporaryImpairmentsIncludedInAccumulatedOtherComprehensiveIncomeLoss	600000	USD
	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	1040400000	USD
CY2017Q3	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	920600000	USD
	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	2784800000	USD
CY2018Q3	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	960900000	USD
	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	2787900000	USD
CY2017Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1410700000	USD
CY2018Q3	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1417600000	USD
CY2017Q4	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	578400000	USD
CY2018Q3	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	539200000	USD
CY2017Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	178900000	USD
CY2018Q3	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	56400000	USD
CY2018Q3	cno	Cash Paid To Reinsurer CashPaidToReinsurer	365000000	USD
	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-214200000	USD
	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-117900000	USD
	cno	Change In Cash And Cash Equivalents Held By Variable Interest Entities ChangeInCashAndCashEquivalentsHeldByVariableInterestEntities	0	USD
CY2018Q3	cno	Common Stock Shares Excluded From Diluted Weighted Average Shares Outstanding CommonStockSharesExcludedFromDilutedWeightedAverageSharesOutstanding	2146000	shares
	cno	Common Stock Shares Excluded From Diluted Weighted Average Shares Outstanding CommonStockSharesExcludedFromDilutedWeightedAverageSharesOutstanding	2214000	shares
CY2017Q4	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position12 Monthsor Longer DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPosition12MonthsorLonger	732600000	USD
CY2018Q3	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position12 Monthsor Longer DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPosition12MonthsorLonger	738300000	USD
CY2017Q4	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position12 Monthsor Longer Accumulated Loss DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPosition12MonthsorLongerAccumulatedLoss	31400000	USD
CY2018Q3	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position12 Monthsor Longer Accumulated Loss DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPosition12MonthsorLongerAccumulatedLoss	52000000	USD
CY2017Q4	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position Lessthan12 Months DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionLessthan12Months	1426400000	USD
CY2018Q3	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position Lessthan12 Months DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionLessthan12Months	5626200000	USD
CY2017Q4	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position Lessthan12 Months Accumulated Loss DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionLessthan12MonthsAccumulatedLoss	11100000	USD
CY2018Q3	cno	Debt Securities Availableforsale Continuous Unrealized Loss Position Lessthan12 Months Accumulated Loss DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionLessthan12MonthsAccumulatedLoss	200900000	USD
CY2017Q4	cno	Debt Securities Availableforsale Unrealized Loss Position DebtSecuritiesAvailableforsaleUnrealizedLossPosition	2159000000	USD
CY2018Q3	cno	Debt Securities Availableforsale Unrealized Loss Position DebtSecuritiesAvailableforsaleUnrealizedLossPosition	6364500000	USD
CY2017Q4	cno	Debt Securities Availableforsale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableforsaleUnrealizedLossPositionAccumulatedLoss	42500000	USD
CY2018Q3	cno	Debt Securities Availableforsale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableforsaleUnrealizedLossPositionAccumulatedLoss	252900000	USD
CY2017Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	366900000	USD
CY2018Q3	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	577800000	USD
CY2017Q4	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	465300000	USD
CY2018Q3	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	753800000	USD
CY2018Q3	cno	Distribution Expense Included In Other Costs And Expenses DistributionExpenseIncludedInOtherCostsAndExpenses	600000	USD
	cno	Distribution Expense Included In Other Costs And Expenses DistributionExpenseIncludedInOtherCostsAndExpenses	13000000	USD
CY2017Q3	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	600000	USD
	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-1800000	USD
CY2018Q3	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	5300000	USD
	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	13200000	USD
CY2017Q4	cno	Equity Securities Fvni EquitySecuritiesFVNI	440600000	USD
CY2018Q3	cno	Equity Securities Fvni EquitySecuritiesFVNI	335500000	USD
CY2017Q4	cno	Equity Securities Fvni Cost EquitySecuritiesFVNICost	420000000	USD
CY2018Q3	cno	Equity Securities Fvni Cost EquitySecuritiesFVNICost	340800000	USD
	cno	Estimated Normalized Annual Taxable Income For Current Year EstimatedNormalizedAnnualTaxableIncomeForCurrentYear	345000000	USD
	cno	Estimated Normalized Annual Taxable Income For Current Year Life Income EstimatedNormalizedAnnualTaxableIncomeForCurrentYearLifeIncome	260000000	USD
	cno	Estimated Normalized Annual Taxable Income For Current Year Nonlife Taxable Income EstimatedNormalizedAnnualTaxableIncomeForCurrentYearNonlifeTaxableIncome	85000000	USD
CY2017Q3	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	17000000	USD
	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	44800000	USD
CY2018Q3	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	15900000	USD
	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	49100000	USD
CY2017Q3	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	-13400000	USD
	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	-13400000	USD
CY2018Q3	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	0	USD
	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	11000000	USD
	cno	Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage	0.29
CY2018Q3	cno	Federal Long Term Tax Exempt Rate FederalLongTermTaxExemptRate	0.0232
CY2018Q3	cno	Feerevenuerelatedtodistributionandmarketingagreements Feerevenuerelatedtodistributionandmarketingagreements	6400000	USD
	cno	Feerevenuerelatedtodistributionandmarketingagreements Feerevenuerelatedtodistributionandmarketingagreements	28800000	USD
	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	52300000	USD
	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	27000000	USD
	cno	Gain Losson Reinsurance Transaction GainLossonReinsuranceTransaction	0	USD
	cno	Gain Losson Reinsurance Transaction GainLossonReinsuranceTransaction	-1067600000	USD
CY2018Q3	cno	Income Loss From Continuing Operations Before Investment Losses And Income Taxes IncomeLossFromContinuingOperationsBeforeInvestmentLossesAndIncomeTaxes	5800000	USD
	cno	Income Loss From Continuing Operations Before Investment Losses And Income Taxes IncomeLossFromContinuingOperationsBeforeInvestmentLossesAndIncomeTaxes	15800000	USD
CY2017Q3	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	41900000	USD
	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	121400000	USD
CY2018Q3	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	33100000	USD
	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	84500000	USD
CY2017Q3	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	-12800000	USD
	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	-12800000	USD
CY2018Q3	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	104800000	USD
	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	104800000	USD
CY2017Q3	cno	Income Tax Expense Benefit Current Valuation Allowance IncomeTaxExpenseBenefitCurrentValuationAllowance	2200000	USD
	cno	Income Tax Expense Benefit Current Valuation Allowance IncomeTaxExpenseBenefitCurrentValuationAllowance	2200000	USD
CY2018Q3	cno	Income Tax Expense Benefit Current Valuation Allowance IncomeTaxExpenseBenefitCurrentValuationAllowance	0	USD
	cno	Income Tax Expense Benefit Current Valuation Allowance IncomeTaxExpenseBenefitCurrentValuationAllowance	0	USD
CY2017Q3	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	29100000	USD
	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	108600000	USD
CY2018Q3	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	-10000000	USD
	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	41400000	USD
CY2018Q3	cno	Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	1100000	USD
	cno	Insurance Policy Benefits InsurancePolicyBenefits	1491700000	USD
	cno	Insurance Policy Benefits InsurancePolicyBenefits	1515600000	USD
CY2017Q4	cno	Investment Borrowings InvestmentBorrowings	1646700000	USD
CY2018Q3	cno	Investment Borrowings InvestmentBorrowings	1646100000	USD
CY2017Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1526900000	USD
CY2018Q3	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1550500000	USD
CY2018Q3	cno	Investments Held In Limited Partnerships InvestmentsHeldInLimitedPartnerships	459100000	USD
CY2018Q3	cno	Loss Limitation Based On Income Of Life Insurance Company LossLimitationBasedOnIncomeOfLifeInsuranceCompany	0.35
CY2018Q3	cno	Loss Limitation Based On Loss Of Non Life Entities LossLimitationBasedOnLossOfNonLifeEntities	0.35
CY2017Q3	cno	Loss Related To Reinsurance Transaction LossRelatedToReinsuranceTransaction	0	USD
	cno	Loss Related To Reinsurance Transaction LossRelatedToReinsuranceTransaction	0	USD
CY2018Q3	cno	Loss Related To Reinsurance Transaction LossRelatedToReinsuranceTransaction	-1067600000	USD
	cno	Loss Related To Reinsurance Transaction LossRelatedToReinsuranceTransaction	-1067600000	USD
	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	2543000000	USD
	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	1966700000	USD
CY2018Q3	cno	Negativecedingcommission Negativecedingcommission	825000000	USD
CY2017Q3	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	325900000	USD
	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	960300000	USD
CY2018Q3	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	332000000	USD
	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	989300000	USD
CY2017Q3	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	52700000	USD
	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	171800000	USD
CY2018Q3	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	85800000	USD
	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	134300000	USD
CY2017Q3	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	0	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	0	USD
CY2018Q3	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	363400000	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	363400000	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction Excluding Cash Expenses NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransactionExcludingCashExpenses	0	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction Excluding Cash Expenses NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransactionExcludingCashExpenses	363400000	USD
	cno	Net Sales Of Trading Securities NetSalesOfTradingSecurities	-94800000	USD
	cno	Net Sales Of Trading Securities NetSalesOfTradingSecurities	-25400000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	-2100000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	800000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	1100000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	-200000	USD
CY2018Q3	cno	Nonoperating Loss Carryforwards NonoperatingLossCarryforwards	2331400000	USD
	cno	Number Of Insurance Subsidiaries That Are Members Of The Federal Home Loan Bank NumberOfInsuranceSubsidiariesThatAreMembersOfTheFederalHomeLoanBank	3	subsidiary
CY2018Q3	cno	Number Of Investments Held By Variable Interest Entities In Default NumberOfInvestmentsHeldByVariableInterestEntitiesInDefault	0	investment
	cno	Number Of Product Distribution Channels NumberOfProductDistributionChannels	3	distribution_channel
	cno	Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws	40	state
CY2017Q3	cno	Numberof Individuals Appointedto Assume Immediate Controland Power Over Affairs NumberofIndividualsAppointedtoAssumeImmediateControlandPowerOverAffairs	2	individual
CY2017Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	1800000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	25300000	USD
CY2018Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-18700000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-107400000	USD
CY2017Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-31000000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-243000000	USD
CY2018Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	106500000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	509500000	USD
CY2017Q3	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	700000	USD
	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	1000000	USD
CY2018Q3	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	-500000	USD
	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	-100000	USD
CY2018Q3	cno	Ownership Change Threshold Restricting Net Operating Loss Usage OwnershipChangeThresholdRestrictingNetOperatingLossUsage	0.5
	cno	Payment To Reinsurer Pursuant To Long Term Care Business Reinsured PaymentToReinsurerPursuantToLongTermCareBusinessReinsured	0	USD
	cno	Payment To Reinsurer Pursuant To Long Term Care Business Reinsured PaymentToReinsurerPursuantToLongTermCareBusinessReinsured	365000000	USD
	cno	Policy Acquisition Costs PolicyAcquisitionCosts	183400000	USD
	cno	Policy Acquisition Costs PolicyAcquisitionCosts	187200000	USD
CY2017Q4	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	-9300000	USD
CY2018Q3	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	17900000	USD
CY2017Q3	cno	Pretaxoperatingearnings Pretaxoperatingearnings	115800000	USD
	cno	Pretaxoperatingearnings Pretaxoperatingearnings	329800000	USD
CY2018Q3	cno	Pretaxoperatingearnings Pretaxoperatingearnings	109000000	USD
	cno	Pretaxoperatingearnings Pretaxoperatingearnings	308000000	USD
	cno	Proceeds From Investment Borrowings Related To Variable Interest Entities ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities	387300000	USD
	cno	Proceeds From Investment Borrowings Related To Variable Interest Entities ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities	277600000	USD
	cno	Purchases Of Investments PurchasesOfInvestments	4076800000	USD
	cno	Purchases Of Investments PurchasesOfInvestments	5037600000	USD
CY2018Q3	cno	Reinsurance Accrued Interest On Investments Transferred ReinsuranceAccruedInterestOnInvestmentsTransferred	51600000	USD
CY2018Q3	cno	Reinsurance Investments Transferred ReinsuranceInvestmentsTransferred	3582100000	USD
CY2018Q3	cno	Reinsurance Present Value Of Future Profits And Deferred Acquisition Costs Writtenoff ReinsurancePresentValueOfFutureProfitsAndDeferredAcquisitionCostsWrittenoff	61600000	USD
CY2018Q3	cno	Reinsurance Pretax Gain Loss ReinsurancePretaxGainLoss	-704200000	USD
CY2018Q3	cno	Reinsurance Receivables Payables ReinsuranceReceivablesPayables	-2818000000	USD
CY2018Q3	cno	Reinsurance Release Of Future Loss Reserve ReinsuranceReleaseOfFutureLossReserve	-189300000	USD
CY2018Q3	cno	Reinsurance Transaction After Tax Charge ReinsuranceTransactionAfterTaxCharge	661100000	USD
CY2018Q3	cno	Reinsurance Transaction Total Impact ReinsuranceTransactionTotalImpact	1067600000	USD
	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	862300000	USD
	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	275900000	USD
CY2017Q3	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	1036400000	USD
	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	3114600000	USD
CY2018Q3	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	1069900000	USD
	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	3095900000	USD
CY2017Q3	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	13700000	USD
	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	40200000	USD
CY2018Q3	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	16700000	USD
	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	49000000	USD
	cno	Sales Of Investments SalesOfInvestments	1723500000	USD
	cno	Sales Of Investments SalesOfInvestments	2747200000	USD
	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	17800000	USD
	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	19600000	USD
CY2018Q3	cno	Statutory Liabilities Transferred Reinsurance Transaction StatutoryLiabilitiesTransferredReinsuranceTransaction	2700000000	USD
	cno	Stock Based Compensation StockBasedCompensation	21600000	USD
	cno	Stock Based Compensation StockBasedCompensation	17100000	USD
CY2018Q3	cno	Stock Repurchase Program Remaining Repurchase Authorized Amount StockRepurchaseProgramRemainingRepurchaseAuthorizedAmount	325100000	USD
CY2017Q3	cno	Tax Benefit On Longterm Care Reinsurance Transaction TaxBenefitOnLongtermCareReinsuranceTransaction	0	USD
	cno	Tax Benefit On Longterm Care Reinsurance Transaction TaxBenefitOnLongtermCareReinsuranceTransaction	0	USD
CY2018Q3	cno	Tax Benefit On Longterm Care Reinsurance Transaction TaxBenefitOnLongtermCareReinsuranceTransaction	147900000	USD
	cno	Tax Benefit On Longterm Care Reinsurance Transaction TaxBenefitOnLongtermCareReinsuranceTransaction	147900000	USD
CY2017Q4	cno	Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpenseBenefit	172500000	USD
	cno	Total Other Than Temporary Impairment Losses On Investments Held By Variable Interest Entities TotalOtherThanTemporaryImpairmentLossesOnInvestmentsHeldByVariableInterestEntities	400000	USD
CY2018Q3	cno	Transaction Expenses And Other TransactionExpensesAndOther	14600000	USD
CY2018Q3	cno	Trust Account Assets Amountof Over Collateralization TrustAccountAssetsAmountofOverCollateralization	500000000	USD
CY2018Q3	cno	Unfunded Commitmentsto Limited Partnerships UnfundedCommitmentstoLimitedPartnerships	231500000	USD
	cno	Valuation Allowance Deferred Tax Asset Valuation Model Forecast Periodof Model ValuationAllowanceDeferredTaxAssetValuationModelForecastPeriodofModel	P5Y
	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	86000000	USD
	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	41900000	USD
	cno	Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments	2200000	USD
	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	-2500000	USD
	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	-3200000	USD
CY2018Q3	cno	Variable Interest Entity Amortized Cost Securities Held VariableInterestEntityAmortizedCostSecuritiesHeld	1553100000	USD
CY2018Q3	cno	Variable Interest Entity Fixed Maturity Securities Fair Value VariableInterestEntityFixedMaturitySecuritiesFairValue	1550500000	USD
CY2017Q3	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-600000	USD
	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-4300000	USD
CY2018Q3	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	0	USD
	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	0	USD
CY2018Q3	cno	Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities	6800000	USD
CY2018Q3	cno	Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities	-9400000	USD
	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	2000000	USD
	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	3400000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001224608
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	164649365	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CNO Financial Group, Inc.
CY2017Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	245900000	USD
CY2018Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	224700000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1212100000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	403500000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1195800000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3073300000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3030000000	USD
CY2017Q3	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	58200000	USD
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	181300000	USD
CY2018Q3	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	62400000	USD
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	195300000	USD
CY2017Q4	us-gaap	Assets Assets	33110300000	USD
CY2018Q3	us-gaap	Assets Assets	31647200000	USD
CY2017Q3	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	7400000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	23100000	USD
CY2018Q3	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	7000000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	21200000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	20702100000	USD
CY2018Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	17929500000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1508700000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1625100000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1601300000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1632800000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1947300000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1496200000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2052300000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1536200000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	11550000000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	9739400000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	13286800000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	10098600000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	328100000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	367700000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	335100000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	372800000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5368000000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	4701100000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5635400000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	4872000000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	22910900000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	18512400000	USD
CY2017Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	949400000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2852000000	USD
CY2018Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2021000000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3837200000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	668200000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	871800000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	757300000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	595600000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	203600000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-161700000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	668200000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	871800000	USD
CY2017Q3	us-gaap	Ceded Premiums Written CededPremiumsWritten	27100000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	79900000	USD
CY2018Q3	us-gaap	Ceded Premiums Written CededPremiumsWritten	25400000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	76000000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.09
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.29
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	166857931	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	164634365	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	166857931	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	164634365	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	1700000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	1600000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	139900000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	557700000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-826500000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1135600000	USD
CY2016Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	300000	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2017Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25900000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	68500000	USD
CY2018Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-16900000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3800000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	914600000	USD
CY2018Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	916200000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	10400000	USD
CY2018Q3	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	8800000	USD
CY2017Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	18200000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	55100000	USD
CY2018Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	50000000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	80700000	USD
CY2017Q3	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-15000000	USD
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-15000000	USD
CY2018Q3	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	104800000	USD
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	104800000	USD
CY2017Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1026800000	USD
CY2018Q3	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1291100000	USD
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	1500000	USD
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	4800000	USD
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	6600000	USD
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	7600000	USD
CY2017Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	42500000	USD
CY2018Q3	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	39700000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	967900000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1049300000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	4300000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	376200000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	559900000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	489600000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	685000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	9300000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	19500000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	48900000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	43800000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	415800000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	301000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	89100000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	193900000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	502600000	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	295500000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	165400000	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	174200000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	0	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	9600000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	337200000	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	111700000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200800000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	216100000	USD
CY2017Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	43300000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	115000000	USD
CY2018Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	92800000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	149400000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	44700000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	48600000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.44
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.07
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.43
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.07
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.342
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.137
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.006
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.347
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.015
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.004
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.013
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.004
CY2017Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	2900000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-9800000	USD
CY2018Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	28200000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	69500000	USD
CY2017Q3	us-gaap	Fees And Commissions FeesAndCommissions	12200000	USD
	us-gaap	Fees And Commissions FeesAndCommissions	35500000	USD
CY2018Q3	us-gaap	Fees And Commissions FeesAndCommissions	11900000	USD
	us-gaap	Fees And Commissions FeesAndCommissions	44700000	USD
CY2017Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	29200000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	52300000	USD
CY2018Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	394600000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	390400000	USD
CY2017Q3	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	34500000	USD
	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	74800000	USD
CY2018Q3	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	33300000	USD
	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	29100000	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5500000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5500000	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3800000	USD
CY2017Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	4700000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	18200000	USD
CY2018Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2100000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2100000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	129900000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	355100000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-539800000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-301900000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	115000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	123600000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-114800000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-63400000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	58000000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	31000000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	50600000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	10500000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	183400000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	187200000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	321500000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	209100000	USD
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2298000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1910000	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017Q3	us-gaap	Interest Expense InterestExpense	30100000	USD
	us-gaap	Interest Expense InterestExpense	92300000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	38800000	USD
	us-gaap	Interest Expense InterestExpense	110100000	USD
	us-gaap	Interest Paid InterestPaid	81000000	USD
	us-gaap	Interest Paid InterestPaid	92800000	USD
CY2017Q4	us-gaap	Investments Investments	27854100000	USD
CY2018Q3	us-gaap	Investments Investments	23355400000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	28262800000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	28027300000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33110300000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31647200000	USD
CY2017Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	530300000	USD
CY2018Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	513400000	USD
CY2017Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11521300000	USD
CY2018Q3	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11140500000	USD
CY2018Q3	us-gaap	Long Term Debt LongTermDebt	925000000	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	500000000	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	425000000	USD
CY2017Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1650600000	USD
CY2018Q3	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	1680600000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-510000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37900000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	264100000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-314600000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	449500000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	100800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	246500000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-529800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-343300000	USD
CY2017Q4	us-gaap	Notes Payable NotesPayable	914600000	USD
CY2018Q3	us-gaap	Notes Payable NotesPayable	916200000	USD
CY2018Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3262100000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	319500000	USD
CY2018Q3	us-gaap	Other Assets OtherAssets	299600000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	61100000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	483200000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-379100000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-1013700000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	39100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	311200000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-296700000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-792300000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	27700000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	44000000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	354700000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	366400000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	22000000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	172000000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-82400000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-221400000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	120900000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	794500000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-149100000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1264100000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	309100000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-791500000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	170900000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-221200000	USD
CY2017Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	217500000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	631300000	USD
CY2018Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	205300000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	608700000	USD
CY2017Q4	us-gaap	Other Investments OtherInvestments	924500000	USD
CY2018Q3	us-gaap	Other Investments OtherInvestments	920000000	USD
CY2017Q4	us-gaap	Other Liabilities OtherLiabilities	751800000	USD
CY2018Q3	us-gaap	Other Liabilities OtherLiabilities	689500000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	74500000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	11700000	USD
CY2017Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	900000	USD
CY2018Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
CY2017Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	4700000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	17300000	USD
CY2018Q3	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	2100000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	2100000	USD
	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	549200000	USD
	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	591900000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	20400000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	16300000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	142300000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	67500000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	44500000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	48400000	USD
CY2017Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	116000000	USD
CY2018Q3	us-gaap	Policy Loans Receivable PolicyLoansReceivable	117400000	USD
CY2017Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	638100000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1941600000	USD
CY2018Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	646900000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1851700000	USD
CY2017Q4	us-gaap	Policyholder Funds PolicyholderFunds	11220700000	USD
CY2018Q3	us-gaap	Policyholder Funds PolicyholderFunds	11449700000	USD
CY2017Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	659300000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	1987200000	USD
CY2018Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	656900000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	1976600000	USD
	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1067200000	USD
	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1129700000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	332000000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	150000000	USD
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	35500000	USD
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	44700000	USD
	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	1859400000	USD
	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	1848100000	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	917900000	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1005700000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3500000	USD
CY2017Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	29200000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	52300000	USD
CY2018Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	31200000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	27000000	USD
CY2017Q3	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	10500000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	34000000	USD
CY2018Q3	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	8600000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	26600000	USD
CY2017Q3	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	22600000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	69100000	USD
CY2018Q3	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	19400000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	63600000	USD
CY2017Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	2175200000	USD
CY2018Q3	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4946300000	USD
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	920800000	USD
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	980500000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	332600000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	150600000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	560400000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	184800000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	576700000	USD
CY2017Q3	us-gaap	Revenues Revenues	1079300000	USD
	us-gaap	Revenues Revenues	3207100000	USD
CY2018Q3	us-gaap	Revenues Revenues	1481200000	USD
	us-gaap	Revenues Revenues	3535300000	USD
CY2017Q4	us-gaap	Separate Account Assets SeparateAccountAssets	5000000	USD
CY2018Q3	us-gaap	Separate Account Assets SeparateAccountAssets	5100000	USD
CY2017Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	5000000	USD
CY2018Q3	us-gaap	Separate Accounts Liability SeparateAccountsLiability	5100000	USD
	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	239000	shares
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	140100000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	60500000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	4486900000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	4881700000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	4847500000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	3619900000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	4847500000	USD
CY2017Q4	us-gaap	Trading Securities TradingSecurities	284600000	USD
CY2018Q3	us-gaap	Trading Securities TradingSecurities	239000000	USD
CY2017Q4	us-gaap	Unearned Premiums UnearnedPremiums	261700000	USD
CY2018Q3	us-gaap	Unearned Premiums UnearnedPremiums	249200000	USD
CY2017Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	359600000	USD
CY2018Q3	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	351600000	USD
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	170982000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	172800000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	164551000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	165903000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	168684000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	170890000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	164551000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165903000	shares
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION AND OTHER LEGAL PROCEEDINGS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.  We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.  The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.  In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.  In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.  Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.  The Company reviews these matters on an ongoing basis.  When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 29, 2016, Washington National and Bankers Conseco Life Insurance Company ("BCLIC") commenced an arbitration proceeding seeking compensatory, consequential and punitive damages against Beechwood Re Ltd. ("BRe") based upon BRe’s incurable material breaches of the long-term care reinsurance agreements, conversion, fraud, and breaches of fiduciary duties and the obligation to deal honestly and in good faith. BRe filed a counterclaim against Washington National and BCLIC in the arbitration alleging damages relating to the reinsurance agreements and their termination. In addition, on September 29, 2016, a complaint was filed by BCLIC and Washington National in the United States District Court for the Southern District of New York, Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Moshe M. Feuer, Scott Taylor and David Levy, Case No. 16-cv-7646, alleging, among other claims, fraud/fraudulent concealment, and violation of the Racketeer Influenced and Corrupt Organizations Act. These allegations relate to the long-term care reinsurance agreements between BRe and Washington National and BCLIC, respectively, and emanate from the undisclosed relationships between and among the defendants (who were the principal owners and officers of BRe) and Platinum Partners, LP and its affiliates. On April 27, 2017, an amended complaint was filed adding Beechwood Capital Group, LLC as a defendant. On March 13, 2018, the District Court granted the motion that had been filed by Feuer, Taylor and Levy to compel arbitration of Washington National's and BCLIC's claims and the litigation is now stayed pending the outcome of the arbitration. Washington National and BCLIC intend to vigorously pursue their claims for damages and other remedies in the arbitration and the litigation described above.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By public notice dated July 26, 2017, the Cayman Islands Monetary Authority advised that, effective July 25, 2017, </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> individuals (the "Controllers") had been appointed pursuant to Section 24(2)(h) of the Cayman Islands Insurance Law to assume control of the affairs of BRe.  According to the public notice, effective with their appointment, the Controllers assumed immediate control of the affairs of BRe and have all the powers necessary to administer the affairs of BRe including power to terminate its insurance business.  The Controllers are responsible for assessing the financial position of BRe and submitting a report to the Cayman Islands Monetary Authority.  On August 10, 2018, the Cayman Islands Monetary Authority filed a public petition in the Grand Court of the Cayman Islands to officially wind up Beechwood, concluding that Beechwood was now of doubtful solvency. We are in the process of assessing the potential impact of this action on the proceedings described in the foregoing paragraph.</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Regulatory Examinations and Fines</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance companies face significant risks related to regulatory investigations and actions.  Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.  We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.  The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries.  Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">40</font><font style="font-family:inherit;font-size:10pt;"> states and the District of Columbia are currently participating in this examination.</font></div></div>

Files In Submission

Name	View Source	Status
0001224608-18-000045-index-headers.html	Edgar Link	pending
0001224608-18-000045-index.html	Edgar Link	pending
0001224608-18-000045.txt	Edgar Link	pending
0001224608-18-000045-xbrl.zip	Edgar Link	pending
cno-20180930.xml	Edgar Link	completed
cno-20180930.xsd	Edgar Link	pending
cno-20180930_cal.xml	Edgar Link	unprocessable
cno-20180930_def.xml	Edgar Link	unprocessable
cno-20180930_lab.xml	Edgar Link	unprocessable
cno-20180930_pre.xml	Edgar Link	unprocessable
cno0930201810-q.htm	Edgar Link	pending
cno09302018ex121.htm	Edgar Link	pending
cno09302018ex311.htm	Edgar Link	pending
cno09302018ex312.htm	Edgar Link	pending
cno09302018ex321.htm	Edgar Link	pending
cno09302018ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
orgchart2017.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNO
CNO Financial Group, Inc. Stock $cno

2018 Q4 Form 10-Q Financial Statement

#000122460818000045 Filed on November 05, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO CNO Financial Group, Inc. Stock $cno

2018 Q4 Form 10-Q Financial Statement

#000122460818000045 Filed on November 05, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO
CNO Financial Group, Inc. Stock $cno